Jm. Fang et al., CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma, MOD PATHOL, 12(3), 1999, pp. 295-300
Citations number
28
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Diffuse large B-cell lymphoma (DLBCL) is a common morphologic term for a bi
ologically diverse group of lymphomas. The chromosome translocation, t(14;1
8)(q32;q21), and its associated bcl-2 gene rearrangement are generally asso
ciated with follicular lymphomas. Some investigators, however, proposed tha
t the presence of the t(14;18) in DLBCL suggests a possible follicle center
cell origin and might correlate with a higher relapse rate after therapy.
The CD10 antigen is expressed in a majority of follicular lymphomas but is
also seen occasionally in DLBCLs. in this study, we examined 26 DLBCLs for
CD10 expression by now cytometric analysis and tested them for the t(14;18)
(q32;q21) major breakpoint region by a polymerase chain reaction-based meth
od, bcl-2 protein expression was analyzed by an immunoperoxidase method. Of
the 26 DLBCLs, 9 (35%) were CD10 positive, bcl-2 protein was expressed in
7 (78%) of 9 CD10-positive cases and in 9 (53%) of 17 CD10-negative cases (
P = .4). The t(14;18) translocation was present in 6 (67%) of 9 CD10-positi
ve cases but in only 2 (17%) of 12 CD10-negative cases (P = .03). Five case
s did not yield amplifiable DNA for analysis. In summary, no difference in
bcl-2 protein expression was seen in CD10-positive versus CD10-negative DLB
CLs, but CD10-positive DLBCLs were significantly more likely than CD10-nega
tive DLBCLs to harbor the t(14;18) translocation. This suggests that CD10 m
ight be a marker of follicle center cell origin in DLBCL.